Part Number
Part Number:
NSN:
NIIN:
Item Name:
DIVALPROEX SODIUM DELAYED-RELEAS
Definition:
CAGE Information
| Code | Company |
|---|---|
| 70048 | ABBOTT LABORATORIES PHARMACEUTICAL P |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| FEAT | SPECIAL FEATURES | CONTAINS SUFFICIENT COATED PARTICLES OF DIVALPROEX SODIUM EQUIVALENT TO 125.000 MILLIGRAMS VALPROIC ACID IN A HARD GELATIN SPRINKLE CAPSULE |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DIVALPROEX SODIUM DELAYED-RELEASE CAPSULES 125MG 100S BT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 125.000 MILLIGRAMS DIVALPROEX SODIUM ACTIVE INGREDIENT |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |